Exclusive Support Services Agreement Between GUANGDONG YIHAO PHARMACY CO., LTD. And YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. September 5, 2013Exclusive Support Services Agreement • May 17th, 2018 • 111, Inc. • Retail-drug stores and proprietary stores
This Exclusive Support Services Agreement (the “Agreement”) is concluded and signed on September 5, 2013 in Shanghai, the People’s Republic of China (“China”) by and between:
YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. And GUANGDONG YIHAO PHARMACY CO., LTD. Regarding GUANGDONG YIHAO PHARMACEUTICAL CHAIN CO., LTD. Exclusive Option Agreement September 5, 2013Exclusive Option Agreement • May 17th, 2018 • 111, Inc. • Retail-drug stores and proprietary stores
This Exclusive Option Agreement (“Agreement”) was made and entered into on September 5, 2013 by and among the following parties in Shanghai, the People’s Republic of China (“China”):
Equity Pledge AgreementEquity Pledge Agreement • May 17th, 2018 • 111, Inc. • Retail-drug stores and proprietary stores
This Equity Pledge Agreement (this “Agreement”) is made in Shanghai, the People’s Republic of China (“PRC”) as of September 5, 2013 by and between:
PROXY AGREEMENT September 5, 2013Proxy Agreement • May 17th, 2018 • 111, Inc. • Retail-drug stores and proprietary stores
This PROXY AGREEMENT (“Agreement”) is made and entered into on September 5, 2013 by and among the following parties in Shanghai, the People’s Republic of China (“China”):
Equity Pledge Agreement regarding GUANGDONG YIHAO PHARMACY CO., LTD. by and between YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD. andEquity Pledge Agreement • May 17th, 2018 • 111, Inc. • Retail-drug stores and proprietary stores
This Equity Pledge Agreement (this “Agreement”) was made in Shanghai, the People’s Republic of China (“PRC”) on July 13, 2017 by and between:
And GUANGDONG YIHAO PHARMACY CO., LTD. PROXY AGREEMENTProxy Agreement • May 17th, 2018 • 111, Inc. • Retail-drug stores and proprietary stores
This PROXY AGREEMENT (“Agreement”) was made and entered into on September 5, 2013 by and among the following parties in Shanghai, the People’s Republic of China (“China”):
Equity Transfer AgreementEquity Transfer Agreement • May 17th, 2018 • 111, Inc. • Retail-drug stores and proprietary stores
Rights and Obligations Assignment AgreementRights and Obligations Assignment Agreement • May 17th, 2018 • 111, Inc. • Retail-drug stores and proprietary stores
NINTH AMENDED AND RESTATED SHAREHOLDERS AGREEMENT by and amongShareholder Agreements • May 17th, 2018 • 111, Inc. • Retail-drug stores and proprietary stores • Hong Kong
THIS NINTH AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (this “Agreement”) is made and entered into as of April 24, 2018 by and among New Peak Group (岗岭集团), an exempted company incorporated, organized and existing under the laws of the Cayman Islands with limited liability (company registration no. 278041) (the “Company”); Gang Yu, a U.S. citizen (passport number: 422050901); Junling Liu, an Australian citizen (passport number: E4085621) (together with Gang Yu, collectively, the “Founders”, and each a “Founder”); Gold Prized Investment Limited, a company organized and existing under the laws of the British Virgin Islands (“Gold Prized”); Ivy Capital 2011 Holdco Ltd., a company organized and existing under the laws of the British Virgin Islands (“Ivy Capital”); Gold Stand Goal Limited, a company organized and existing under the laws of the British Virgin Islands (“Gold Stand”, together with Ivy Capital, collectively, the “Series A Investors” and each a “Series A Investor”); ClearVue YW H
